True Wealth Design’s Neuropace NPCE Stock Holding History

True Wealth Design’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-6	Closed	-$96	–	2716
2026 Q2	$96	Buy	+6	New	+$97	﹤0.01%	2543
2025 Q3	–	Sell	-10	Closed	-$112	–	2826
2025 Q2	$112	Buy	10 +4	+67%	+$50	﹤0.01%	2214
2025 Q1	$74	Buy	+6	New	+$75	﹤0.01%	2291

Other funds holding NPCE

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

True Wealth Design's NPCE Position: Q3 2026 in Review

True Wealth Design sold out of Neuropace (NPCE) in Q3 2026, closing a stake of 6 shares — an estimated $96 sold.

True Wealth Design first reported a position in NPCE in Q1 2025 and held it in 3 quarters. The position peaked at $112 in Q2 2025. 3 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

True Wealth Design reported no remaining Neuropace position as of Q3 2026 after selling out during the quarter.
True Wealth Design sold 6 Neuropace shares in Q3 2026, an estimated $96.
True Wealth Design first reported a position in Neuropace in Q1 2025 and held it in 3 quarters.
True Wealth Design's Neuropace position peaked at $112 in Q2 2025.
3 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.